S Viglino

Università degli Studi di Genova, Genova, Liguria, Italy

Are you S Viglino?

Claim your profile

Publications (3)0.47 Total impact

  • Article: Computed tomography in the evaluation of advanced cervical cancer.
    [show abstract] [hide abstract]
    ABSTRACT: The authors evaluate the reliability of computed axial tomography in the staging of cervical cancer. This technique, neither invasive nor dangerous for the patient allowed to define better the involvement of perirectal fat tissue and of the external layer of the rectal wall. On the other hand it has some limits, in particular it is aspecific and unable to define exactly morphological changes of lymph-nodes and other structures.
    European journal of gynaecological oncology 02/1983; 4(3):201-4. · 0.47 Impact Factor
  • Article: [Effects of hormonal contraception on benign changes of the breast].
    Minerva ginecologica 12/1982; 34(11):889-94.
  • Article: Oral contraception and breast pathology.
    N Ragni, E Boccardo, S Viglino, E Larosa
    [show abstract] [hide abstract]
    ABSTRACT: After a rapid examination of the international literature concerning human, animal, histological and epidemiological experimental data, the Authors state that the use of oral contraceptives considerably reduces the risk of benign disease of the breast. This risk reduction seems to be connected to the presence of progestin in this type of contraception. The Authors then expound the data regarding a group of patients (3527), who came to the center for the diagosis and prevention of cancer of the breast at the S. Martino hospital of Genoa during the years 1977-1980. The results of the study are comparable to those found in international literature, in that they confirm the protective effect of hormonal contraception on benign pathology of the breast. Finally we have shown the data of the retrospective and prospective studies conducted up till now on the effects of hormonal contraception on malignant breast pathology. In conclusion we have shown which lines of study should be taken in order to clarify once and for all the links existing between estroprogestins and cancer of the breast.
    Acta Europaea fertilitatis 07/1981; 12(2):141-63.